• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁(氧)氢氧化物核壳纳米粒子中磷酸盐的相互作用和机制。

Interaction and mechanisms in the phosphate-binding of iron(oxyhydr)oxide core-shell nanoparticles.

机构信息

Fraunhofer Institute for Process Engineering and Packaging (IVV), Giggenhauser Str. 35, 85354 Freising, Germany; Chair of Bioseparation Engineering, School of Engineering and Design, Technical University of Munich, Boltzmannstraße 15, 85748 Garching, Germany.

Chair of Bioseparation Engineering, School of Engineering and Design, Technical University of Munich, Boltzmannstraße 15, 85748 Garching, Germany; Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, 02139 Cambridge, MA, United States; Division of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz, Neue Stiftingtalstraße 6, 8010 Graz, Austria; BioTechMed-Graz, Austria.

出版信息

J Colloid Interface Sci. 2023 Mar 15;634:418-430. doi: 10.1016/j.jcis.2022.12.035. Epub 2022 Dec 10.

DOI:10.1016/j.jcis.2022.12.035
PMID:36542971
Abstract

HYPOTHESIS

The high binding affinity of iron(oxyhydr)oxides for phosphate has recently been used in medicine to treat hyperphosphatemia, an abnormally elevated phosphate concentration in the blood. For iron(oxyhydr)oxide nanoparticles, the composition of the organic shell has a more significant influence on their interaction with phosphate than is often assumed. This study shows different mechanisms in phosphate binding, using the example of two similar new phosphate-binding agents.

EXPERIMENTS

We characterized the phosphate-binding behavior of two iron(oxyhydr)oxide-based nanomaterials with similar composition and particle properties and investigated their binding mechanisms by spectroscopic methods.

FINDINGS

For the often prescribed Velphoro, we demonstrated a phosphate binding capacity of>210 mg/g. A similar active ingredient named C-PAM binds over 573 mg/g. Spectroscopic measurements highlighted differences in the binding mechanism. While Velphoro binds phosphate via surface complexation independent of pH and adsorbent concentration, C-PAM shows a strong concentration dependence. At low concentrations, phosphate is bound via complexation reactions. The iron(oxyhydr)oxide structure was dissolved at higher phosphate concentrations and formed various iron phosphate species. The substances behave differently upon interaction with phosphate, although being very similar in composition and crystal structure. Thus, we demonstrated a crucial influence of the ligands in the shell on the binding mechanism.

摘要

假设

最近,铁(氧)氢氧化物对磷酸盐的高亲和力已被用于医学治疗高磷酸盐血症,即血液中磷酸盐浓度异常升高。对于铁(氧)氢氧化物纳米粒子,有机壳的组成对其与磷酸盐的相互作用的影响比人们通常认为的要大得多。本研究以两种类似的新型磷酸盐结合剂为例,展示了不同的磷酸盐结合机制。

实验

我们用两种组成和颗粒性质相似的铁(氧)氢氧化物基纳米材料来描述其对磷酸盐的结合行为,并通过光谱方法研究了它们的结合机制。

发现

对于常用的 Velphoro,我们证明其磷酸盐结合能力大于 210 mg/g。一种名为 C-PAM 的类似有效成分可结合超过 573 mg/g 的磷酸盐。光谱测量突出了结合机制的差异。Velphoro 通过与 pH 和吸附剂浓度无关的表面络合来结合磷酸盐,而 C-PAM 则表现出很强的浓度依赖性。在低浓度下,磷酸盐通过络合反应结合。在较高的磷酸盐浓度下,铁(氧)氢氧化物结构溶解并形成各种铁磷酸盐。这些物质在与磷酸盐相互作用时表现出不同的行为,尽管它们在组成和晶体结构上非常相似。因此,我们证明了壳层中的配体对结合机制有重要影响。

相似文献

1
Interaction and mechanisms in the phosphate-binding of iron(oxyhydr)oxide core-shell nanoparticles.铁(氧)氢氧化物核壳纳米粒子中磷酸盐的相互作用和机制。
J Colloid Interface Sci. 2023 Mar 15;634:418-430. doi: 10.1016/j.jcis.2022.12.035. Epub 2022 Dec 10.
2
Characterization of an active ingredient made of nanoscale iron(oxyhydr)oxide for the treatment of hyperphosphatemia.用于治疗高磷血症的纳米级铁(氢)氧化物活性成分的特性研究。
RSC Adv. 2021 May 14;11(29):17669-17682. doi: 10.1039/d1ra00050k. eCollection 2021 May 13.
3
Pilot-scale co-precipitation synthesis of a novel active ingredient made of ultrasmall iron (oxyhydr)oxide nanoparticles for the treatment of hyperphosphatemia.中试规模共沉淀法合成用于治疗高磷血症的由超小铁(氢)氧化物纳米颗粒制成的新型活性成分。
RSC Adv. 2024 May 20;14(23):16117-16127. doi: 10.1039/d4ra02719a. eCollection 2024 May 15.
4
Sorption of copper and phosphate to diverse biogenic iron (oxyhydr)oxide deposits.多种生物成因铁(氧)氢氧化物沉积物对铜和磷酸盐的吸附。
Sci Total Environ. 2019 Dec 20;697:134111. doi: 10.1016/j.scitotenv.2019.134111. Epub 2019 Aug 26.
5
The hollow core-shell ferric oxide entrapped chitosan microcapsules as phosphate binders for phosphorus removal in vitro.空心核壳氧化铁包埋壳聚糖微胶囊作为体外除磷的磷结合剂。
Carbohydr Polym. 2021 Apr 1;257:117621. doi: 10.1016/j.carbpol.2021.117621. Epub 2021 Jan 7.
6
Incorporation of iron (oxyhydr)oxide nanoparticles with expanded graphite for phosphorus removal and recovery from aqueous solutions.将铁(氧)氢氧化物纳米颗粒与膨胀石墨结合,从水溶液中去除和回收磷。
Chemosphere. 2020 Nov;259:127395. doi: 10.1016/j.chemosphere.2020.127395. Epub 2020 Jun 23.
7
Kinetic ATR-FTIR studies on phosphate adsorption on iron (oxyhydr)oxides in the absence and presence of surface arsenic: molecular-level insights into the ligand exchange mechanism.动力学衰减全反射傅里叶变换红外光谱研究砷存在和不存在时铁(氧)氢氧化物对磷酸盐的吸附:配体交换机制的分子水平见解。
J Phys Chem A. 2012 Oct 18;116(41):10143-9. doi: 10.1021/jp308913j. Epub 2012 Oct 9.
8
Sorption of phosphate and silicate alters dissolution kinetics of poorly crystalline iron (oxyhydr)oxide.磷酸盐和硅酸盐的吸附改变了非晶质铁(氧)氢氧化物的溶解动力学。
Chemosphere. 2019 Nov;234:690-701. doi: 10.1016/j.chemosphere.2019.06.071. Epub 2019 Jun 21.
9
Effect of phytic acid and morphology on Fe (oxyhydr)oxide transport under saturated flow condition.在饱和流条件下,植酸和形态对 Fe(氧氢)氧化物迁移的影响。
J Hazard Mater. 2022 Feb 15;424(Pt D):127659. doi: 10.1016/j.jhazmat.2021.127659. Epub 2021 Nov 1.
10
Adsorption of double-stranded ribonucleic acids (dsRNA) to iron (oxyhydr-)oxide surfaces: comparative analysis of model dsRNA molecules and deoxyribonucleic acids (DNA).双链核糖核酸(dsRNA)在铁(氧)氢氧化物表面的吸附:模型 dsRNA 分子与脱氧核糖核酸(DNA)的比较分析。
Environ Sci Process Impacts. 2021 Apr 28;23(4):605-620. doi: 10.1039/d1em00010a.

引用本文的文献

1
Pilot-scale co-precipitation synthesis of a novel active ingredient made of ultrasmall iron (oxyhydr)oxide nanoparticles for the treatment of hyperphosphatemia.中试规模共沉淀法合成用于治疗高磷血症的由超小铁(氢)氧化物纳米颗粒制成的新型活性成分。
RSC Adv. 2024 May 20;14(23):16117-16127. doi: 10.1039/d4ra02719a. eCollection 2024 May 15.